Navigation Links
Champions Oncology Reports Financial Results for the Quarter Ended October 31, 2012
Date:12/13/2012

ties and other factors.  Although the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and Champions Oncology's future results, levels of activity, performance or achievements may not meet these expectations.  The Company does not intend to update any of the forward-looking statements after the date of this press release to conform these statements to actual results or to changes in Champions Oncology's expectations, except as required by law.

Contact:
Susan Foreman
410-369-0365
sforeman@championsoncology.com Champions Oncology, Inc.
(Dollars in thousands except per share amounts)Reconciliation of GAAP to Non-GAAP Net LossThree Months Ended October 31,Six Months Ended October 31,2012201120122011Net loss – GAAP

($1,974)

($2,349)

($3,297)

($4,387)Less:

624

855

1,364

1,868  Stock-based compensationNet loss - non-GAAP

($1,350)

($1,494)

($1,933)

($2,519) Reconciliation of GAAP to Non-GAAP Earnings Per Share (EPS)Three Months Ended October 31,Six Months Ended October 31,2012201120122011EPS – GAAP

($0.04)

($0.05)

($0.07)

($0.09)Less:

0.01

0.02

0.03

0.04Effect of stock-based compensation on EPSEPS - non-GAAP

($0.03)

($0.03)

($0.04)

($0.05) Condensed Consolidated Statements of Operations (Unaudited)Three MonthsEnded October 31,Six MonthsEnded October 31,2012201120122011POS operating revenue

$459

$590

$1,377

$1,188TOS operating revenue

999

1,151

2,187

2,184  Total operating revenue$1,458$1,741$3,564$3,372Cost of POS

582

461


'/>"/>
SOURCE Champions Oncology, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities
2. Champions Oncology Reports Financial Results for the Year Ended April 30, 2012
3. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
4. OvaGene Oncology Collaborates With Moffitt Cancer Center to Develop and Commercialize microRNAs Associated With Chemotherapeutic Drug Response
5. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
6. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
7. 500 Oncology Providers Sign Up for Navigating Cancers Patient Engagement Portal
8. Symphogen Grants Exclusive Worldwide License of Phase II Oncology Drug Candidate Sym004 to Merck KGaA
9. New Boehringer Ingelheim Oncology Data to be Presented at ESMO 2012 Congress
10. International Oncology Innovators Meeting in Hamburg
11. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... , Sept. 12, 2014 Research ... "Global Dry Film Photoresist Industry Report 2014" ... Dry Film Photoresist Industry Report 2014 is a professional ... global dry film photoresist industry . The ... definitions, classifications, applications and industry chain structure. The dry ...
(Date:9/12/2014)... -- On Thursday, September 11, 2014, the NASDAQ ... Average finished the day 0.12% lower at 17,049.00, and the ... broad based as seven out of ten sectors ended the ... ended the day at 741.83, down 0.33%, while the index ... initiated coverage on the following equities: Exelixis Inc. (NASDAQ: ...
(Date:9/11/2014)... RURO, Inc., a leading laboratory ... and sample management solutions provider, announces the release ... on the most recent version of its Limfinity® ... seen mass adoption, especially from multi-license environment customers. ... brought an entirely new User Interface and version ...
(Date:9/11/2014)... Lab researchers believes it has uncovered the secret ... layers of transition metal dichalcogenide (TMDC) materials, the ... and photonic applications. , Using two-photon excitation ... one of the most promising of 2D materials, ... dark states energy states in which single ...
Breaking Biology Technology:Global Dry Film Photoresist Industry Report 2014 2Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 2Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 3Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 4Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 5Limfinity® Version 5.1 Available 2Excitonic dark states shed light on TMDC atomic layers 2Excitonic dark states shed light on TMDC atomic layers 3
... Feb. 28, 2011 Idenix Pharmaceuticals, Inc. (Nasdaq: ... discovery and development of drugs for the treatment of ... the fourth quarter and year ended December 31, 2010. ... totaled $46.1 million. Business HighlightsIDX184 ...
... SAN DIEGO, Feb. 28, 2011 Verenium Corporation (Nasdaq: ... of high-performance specialty enzymes, today announced that Terminal 6, ... has successfully begun use of Verenium,s Purifine enzymatic degumming ... Argentina. Purifine enzymatic degumming is a novel process that ...
... (CTI) (Nasdaq and MTA: CTIC) announced today that it ... Conference on Thursday, March 3rd at 10:25 AM Pacific ... Center, Seattle, Washington. WBBA Life Science Innovation Northwest ConferenceCTI ... PM CETRoom 607, Washington State Conference CenterMedia Contact:Dan Eramian ...
Cached Biology Technology:Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2010 Financial Results 2Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2010 Financial Results 3Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2010 Financial Results 4Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2010 Financial Results 5Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2010 Financial Results 6Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2010 Financial Results 7World's Largest Soybean Processing Industrial Complex Converts Half of Capacity to Usage of Verenium's Purifine® PLC Enzymatic Degumming Process Engineered and Installed by Alfa Laval 2World's Largest Soybean Processing Industrial Complex Converts Half of Capacity to Usage of Verenium's Purifine® PLC Enzymatic Degumming Process Engineered and Installed by Alfa Laval 3World's Largest Soybean Processing Industrial Complex Converts Half of Capacity to Usage of Verenium's Purifine® PLC Enzymatic Degumming Process Engineered and Installed by Alfa Laval 4
(Date:9/12/2014)... extraction of type I collagen fibrils, in vitro as ... circular cross sections stay distributed in a range going ... of them. Jean Charvolin and Jean-Francois Sadoc from the ... therefore that, once the growth of the fibrils has ... be limited by internal physical stresses generated during the ...
(Date:9/12/2014)... strange thing happened on the way to dealing ... trillions of dollars, worth of previously unreachable oil ... environmental costs and benefits from "fracking," ... and chemicals deep into underground rock formations, are ... academic studies and government databases. The survey covers ...
(Date:9/12/2014)... Washington , September 12, 2014 ... source covering leading sectors including biometrics and mobile tech, issues ... launch of Apple Pay, its new payment service. ... founder of the Secure Identity and Biometrics Association (SIBA) and ... NXTD ) a company that is introducing its own ...
Breaking Biology News(10 mins):Conjecture on the lateral growth of Type I collagen fibrils 2Stanford-led study assesses the environmental costs and benefits of fracking 2Stanford-led study assesses the environmental costs and benefits of fracking 3Stanford-led study assesses the environmental costs and benefits of fracking 4Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 2Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 3Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 4Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 5
... the largest scientific conference devoted primarily to osteoporosis, will ... session focused on four key topics in nutrition and ... the MRC Epidemiology Resource Centre at the University of ... the University of Oxford, will speak on the developmental ...
... improve forecasts of dust storms in the American Southwest ... announced the finding as a five-year NASA-funded project nears ... of the University of New Mexico in Albuquerque, and ... scientists evaluated the influence of space-based observations on predictions ...
... year, some 29,000 adults and 2,000 children are diagnosed with ... abnormal production of white blood cells in the bone marrow. ... also destroys normal cells. But what if a way could ... A team of Syracuse University researchers believes it may have ...
Cached Biology News:Nutrition and bone health session to open the IOF World Congress on Osteoporosis in Bangkok 2NASA-enhanced dust storm predictions to aid health community 2NASA-enhanced dust storm predictions to aid health community 3Syracuse University researchers discover new way to attack some forms of leukemia 2Syracuse University researchers discover new way to attack some forms of leukemia 3
... expression of an N-terminal FLAG® fusion and ... marker from bicistronic mRNA. Two genes ... for transcription of a single message from ... for protein-protein interaction studies, multi-subunit proteins, and ...
Mouse monoclonal antibody raised against a partial recombinant PRG4. NCBI Entrez Gene ID = PRG4...
Mouse monoclonal antibody raised against a partial recombinant FAAH. NCBI Entrez Gene ID = FAAH...
Mouse monoclonal antibody raised against a partial recombinant ZNF167. NCBI Entrez Gene ID = ZNF167...
Biology Products: